Jin Medical International Ltd. (ZJYL)

Jin Medical International Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	9.08	7.46	8.14	6.93	4.79	3.67
Short-Term Investments	21.02	22.17	18.62	9.77	2.28	2.05
Cash & Short-Term Investments	30.1	29.63	26.76	16.7	7.07	5.73
Cash Growth	1.60%	10.74%	60.24%	136.23%	23.43%	101.69%
Accounts Receivable	5.51	5.91	8.46	4.23	4.08	4.86
Other Receivables	0.02	-	0.1	4.24	0.04	0.41
Total Trade Receivables	5.53	5.91	8.56	8.47	4.12	5.27
Inventory	5.75	4.92	5.17	5.05	6.72	6.89
Other Current Assets	3.17	3.68	2.33	0.89	0.99	1.53
Total Current Assets	44.56	44.14	42.82	31.12	18.9	19.42
Net Property, Plant & Equipment	9.9	7.98	1.72	1.48	1.63	2.11
Other Intangible Assets	1.12	1.1	1.15	0.15	0.16	0.19
Other Long-Term Assets	0.26	0.14	0.12	0.15	0.25	0.18
Total Assets	55.84	53.37	45.8	32.9	20.94	21.9

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Accounts Payable	2.6	3.26	3.01	3.39	4.11	5.35
Accrued Expenses	0.51	0.67	0.43	0.32	0.39	0.72
Short-Term Debt	17.98	18.84	11.32	4.11	-	-
Current Portion of Leases	0.06	0.07	0.19	-	-	-
Unearned Revenue	0.64	0.61	0.8	0.83	0.83	1.68
Other Current Liabilities	1.04	0.34	1.4	0.27	0.37	0.12
Total Current Liabilities	22.82	23.8	17.15	8.92	5.7	7.87
Long-Term Debt	2.87	-	-	-	-	-
Long-Term Leases	-	-	0.1	-	-	-
Total Long-Term Liabilities	2.87	-	0.1	-	-	-
Total Liabilities	25.69	23.8	17.25	8.92	5.7	7.87

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0.01
Additional Paid-in Capital	6.75	6.75	6.75	6.44	0.08	0.08
Accumulated Other Comprehensive Income	-0.14	-0.92	-0.56	-1.4	-0.91	0.59
Retained Earnings	23.7	23.81	22.61	18.94	16.06	13.35
Total Common Shareholders' Equity	30.32	29.64	28.82	23.98	15.24	14.03
Minority Interest	-0.17	-0.07	-0.26	-	-	-
Shareholders' Equity	30.15	29.57	28.55	23.98	15.24	14.03
Total Liabilities & Equity	55.84	53.37	45.8	32.9	20.94	21.9

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Total Debt	20.9	18.91	11.6	4.11	0	0
Net Cash (Debt)	9.2	10.72	15.15	12.59	7.07	5.73
Net Cash Growth	-14.18%	-29.26%	20.41%	78.04%	23.43%	2879.90%
Net Cash Per Share	1.18	1.37	1.94	1.73	1.05	0.85
Book Value	30.32	29.64	28.82	23.98	15.24	14.03
Book Value Per Share	3.87	3.79	3.68	3.30	2.26	2.08
Tangible Book Value	29.2	28.54	27.67	23.82	15.07	13.84
Tangible Book Value Per Share	3.73	3.65	3.54	3.28	2.23	2.05

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: Aug 4, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 10, 2026

Data Sources Report a data error